Organisation: Sense Biodetection Limited.

Location: St Ives, Cambridgeshire, UK.

Based at the Edinburgh BioQuarter, RoslinCT is a leading Contract Manufacturing and Development Organisation within the cellular therapies/ATMPs field, performing cutting edge investigational medicinal product manufacture for clinical trials across Europe and the US.

The Company is now embarking on an exciting period of planned growth, and we are recruiting for some key operational roles to help support and lead that growth into the future.


Salary: £24,000 - £26,000 per annum

Contract Type: Permanent, full-time 35 hours

Location: CRT Cambridge laboratory – Cambridge (Babraham)

Closing date: 15th November 2020, 23:55pm


ExecMind is a Life Science Executive Search company focused on recruitment of top scientists and management in global biotech and medtech industries.

Director/Lead in DMPK in small molecules oncology therapies

Location: Poland

Together with an innovative European biotech company, we are looking for a Director/Lead in DMPK, with strong technical and problem-solving skills.

Isomerase is an innovative, growing biotechnology company based at Chesterford Research Park near Cambridge, UK. It was founded in 2012 and has particular expertise in synthetic biology, bioengineering and the discovery and development of the next generation of microbial natural products and peptides. The Company is growing rapidly and has recently moved into a new HQ facility in Cambridge. As part of this exciting phase of growth, we are also looking to recruit a talented and enthusiastic Research Associate to join our biology team.

At TTP we create innovative products and breakthrough technologies for our clients. Multidisciplinary teams of scientists, engineers and designers collaborate closely to solve complex problems to realise our clients’ most ambitious visions.

Healthcare innovation at TTP

Isomerase is one of the UK’s leading biotechnology contract research organisations specialising in synthetic biology, strain bioengineering, fermentation process development and scale-up. We work in partnership with global companies to research, develop and manufacture products such as life-saving new medicines and other novel microbially-derived natural products.

Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.